Prenatal cannabis use significantly increases the risks of low birth weight and fetal death, highlighting the need for greater education on its dangers during pregnancy.
US-China tensions threaten to ensnare additional Chinese biopharma contractors
In recent weeks, proposed federal legislation has forced US drugmakers to rethink their relationship with a Chinese company that’s a staple in drug development. Now,
April 5, 2024